U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Apple Tree Goat Dairy - 509219 - 09/30/2021
  1. Warning Letters

CLOSEOUT LETTER

Apple Tree Goat Dairy MARCS-CMS 509219 —

Delivery Method:
VIA Electronic Mail
Product:
Food & Beverages

Recipient:
Recipient Name
Linda H. Nussbaum
Recipient Title
Co-Owner
Apple Tree Goat Dairy

129 North Nenix Hill Rd
Richfield, PA 17086-8555
United States

appletreegoatdairy@emypeople.net
Issuing Office:
Human & Animal Food Division East II

United States


Dear Linda Nussbaum,

The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter 17-PHI-04, dated February 10, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations, or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Daniel W. Johnson
Compliance Officer
HAF Division East 2, Philadelphia Office
Office phone: 215.717.3746
e-mail: Daniel.Johnson@fda.hhs.gov


Cc (via email):
Randy F. Pack, Program Division Director, District Director (randy.pack@fda.hhs.gov)
Kyle Hobson, State Liaison (Kyle.Hobson@fda.hhs.gov)
Robin M. Rivers, Director, Compliance Branch (Robin.Rivers@fda.hhs.gov)
Martin J. Guardia, Director, Investigations Branch (martin.guardia@fda.hhs.gov)
Margaret E. DiGennaro, Supervisory Consumer Safety Officer (Margaret.DiGennaro@fda.hhs.gov)

Back to Top